SCHEDULE OF OUTSTANDING AND EXERCISABLE (Details) - Warrant [Member] - $ / shares |
3 Months Ended | |
|---|---|---|
Jan. 31, 2025 |
Oct. 31, 2024 |
|
| Range of Exercise Prices | $ 6.56 | |
| Number of Warrants Outstanding | 300,000 | 300,000 |
| Shares, Warrants exercisable | 300,000 | |
| Weighted Average Remaining Contractual Life | 1 year 1 month 6 days | |
| Weighted Average Exercise Price | $ 6.56 | $ 6.56 |
| X | ||||||||||
- Definition Number of equity instruments other than options exercisable, including both vested and non-vested instruments. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average remaining contractual term. No definition available.
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|